TrialBMC cancer2021

Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial.

Stefan Knop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.